Brightsurf Science News & Current Events

June 13, 2009
Tracking levels of key biomarkers reflects disease activity and progression of rheumatoid arthritis
New research has identified biomarkers associated with inflammation and progression in joint erosion in individuals with early rheumatoid arthritis, according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

Increased levels of certain cytokines and chemokines predict onset of rheumatoid arthritis
Up-regulation of certain cytokines and chemokines (signaling molecules involved in the functioning of the immune system) can predict the development of rheumatoid arthritis three years before the onset of symptoms, according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

Canakinumab shows promising efficacy and tolerability in children with systemic JIA
Canakinumab, a new interleukin-1-beta blocking monoclonal antibody, shows encouraging efficacy and is well tolerated in children with systemic juvenile idiopathic arthritis, according to a new phase II study presented today at PReS 2009, a joint congress with the 2009 Congress of the European League Against Rheumatism in Copenhagen, Denmark.

The Earth's magnetic field remains a charged mystery
Professor Gregory Ryskin from the McCormick School of Engineering and Applied Science at Northwestern University in Illinois, US, has defied the long-standing convention by applying equations from magnetohydrodynamics to our oceans' salt water (which conducts electricity) and found that the long-term changes (the secular variation) in the Earth's main magnetic field are possibly induced by our oceans' circulation.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.